Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugsHospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

SUBMITTED BY PGMCINTOSH ON TUE, 04/09/2012 - 11:39

A study by the SDRN Epidemiology Group.

Aims/hypothesis
Current drug labels for thiazolidinediones (TZDs) warn of increased fractures, predominantly for distal fractures in women. We examined whether exposure to TZDs affects hip fracture in women and men and compared the risk to that found with other drugs used in diabetes.

Tags:

Read more

Integrating Research & Clinical Care

SUBMITTED BY PGMCINTOSH ON WED, 22/08/2012 - 10:59

All Scottish Diabetes Research Nurses are invited to a study day ‘Integrating Research and Clinical Care’ in Dundee on Thursday 8th November 2012. This is designed to be an interactive day and we would like each site to bring at least one case study of where care of the patient during a research study has had a direct effect on their clinical care.Please complete the registration form below and return to Paul McIntosh (registrations received after 1st November cannot be accepted).

SDRN can pay travel expenses for staff directly employed by the Network only.

Tags:

Read more

Socioeconomic status and cardiovascular mortality in people with type 2 diabetes mellitus in Scotland

SUBMITTED BY PGMCINTOSH ON WED, 15/08/2012 - 12:24

Aims/hypothesis
The aim of this study was to explore the relationships between type 2 diabetes mellitus, area-based socioeconomic status (SES) and cardiovascular disease mortality in Scotland.

Tags:

Read more

NRS Launch Conference 2012

SUBMITTED BY PGMCINTOSH ON WED, 01/08/2012 - 13:36

“Clinical Research in Partnership”

Tags:

Read more